Skip to main content
Caplight Logo









Gnubiotics Sciences SA

Gnubiotics Sciences SA

Private
EpalingesHealthcare & Life Scienceshttps://gnubiotics.com/

Last Round

Grant

Jul 6, 2022

Total Funding Raised

$7.49M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Gnubiotics Sciences SA is a biotechnology company that develops glycan-based solutions and functional ingredients to improve microbiome health in humans and companion animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

microbiome therapeuticsglycan-based therapeuticsfunctional ingredientsgut healthmicrobiome modulationpet gut healthbiotech R&Dpet nutritionbiotech platformdrug discoveryglycopeptide therapeuticsprecision medicinegut health supplementsmicrobiome biomarkersbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gnubiotics Sciences SA Comparables

Compare Gnubiotics Sciences SA with similar companies based on industry and business-model similarity.

Gnubiotics Sciences SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sweetech
77%
Inbiose
70%
dsm-firmenich
68%

Gnubiotics Sciences SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 6, 2022
Series AJul 30, 2020
DebtJul 30, 2020
Convertible DebtDec 28, 2017
AcceleratorMay 29, 2017

Key People

Founding team and executive leadership

Bernardo Horta e Costa

Co-founder & CFO

Founding Team

Gnubiotics Sciences SA Investors

Notable investors and investment history

Gnubiotics Sciences SA investors
InvestorRounds
Canton of VaudDebt
InnosuisseGrant
Venture KickAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors increased 204% MoM to 1.1K.

  • Oct 12, 2024

    Monthly visitors grew 202% MoM, reaching 1.3K.

Gnubiotics Sciences SA Filings

Explore SEC and related filing metadata, where available.

Gnubiotics Sciences SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Gnubiotics Sciences SA's valuation, stock price, and market status.

Is Gnubiotics Sciences SA a public or private company?

Gnubiotics Sciences SA is a private company.

What is the current stock price of Gnubiotics Sciences SA?

Gnubiotics Sciences SA is a private company with no public stock price. No recent secondary market data is available.

How much is Gnubiotics Sciences SA worth (valuation)?

Valuation information for Gnubiotics Sciences SA is not publicly available.

Can I buy Gnubiotics Sciences SA stock?

Gnubiotics Sciences SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Gnubiotics Sciences SA's last funding round?

Gnubiotics Sciences SA's most recent funding round was Grant on July 6, 2022.

Who are the main investors in Gnubiotics Sciences SA?

Key investors in Gnubiotics Sciences SA include Canton of Vaud, Innosuisse, Venture Kick.

Will Gnubiotics Sciences SA IPO soon?

No public IPO plans have been announced for Gnubiotics Sciences SA.

How can I track Gnubiotics Sciences SA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gnubiotics Sciences SA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEpalinges
Employee Range4
Year Founded2016
Last FundingJul 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?